BioSpace News Archive

Biotech Beach

GT Biopharma Demonstrates Novel B7-H3 Targeting Dual Camelid Nanobody BiKE and GTB-5550 Induce NK Cell Activation Against Broad Spectrum of Tumors at ESMO IO Congress 2021

GT Biopharma, Inc. today announced that the Company’s mini-poster presentation abstract is now broadly available on the European Society for Medical Oncology (“ESMO”) Immuno-Oncology (“IO”) Congress 2021 abstracts webpage.

December 8, 2021
·
9 min read
BioCapital

KeifeRx Completes $6 Million Series A Financing and Enhances Board of Directors

Financing and Board appointments provide foundation for KeifeRx to accelerate development of its pipeline of optimized tyrosine kinase inhibitors targeting neurodegenerative diseases.

December 8, 2021
·
6 min read
Policy

Cybin Confirms Scientific Advice Meeting with UK Medical and Healthcare Products Regulatory Agency for Lead Candidate CYB003 for the Treatment of Major Depressive Disorder and Alcohol Use Disorder

Cybin Inc. is pleased to announce that it has confirmed a scientific advice meeting with the UK Medical and Healthcare Products Regulatory Agency (“ MHRA ”) for the first quarter of calendar year 2022.

December 8, 2021
·
6 min read
Lexaria’s DehydraTECHTM-CBD Reduces Arterial Stiffness, Results Confirmed in Human Clinical Study HYPER-H21-2

Lexaria Bioscience Corp. is pleased to issue follow-up results from human clinical study HYPER-H21-2 confirming that DehydraTECH TM -processed cannabidiol reduces arterial stiffness, potentially broadening its application to treatment of cardiovascular and other disease states beyond hypertension where it has already shown tremendous promise.

December 8, 2021
·
8 min read
Business

Medable and Vault Health Partner to Expand Direct-to-Patient Testing and eCare for Decentralized Clinical Trials

Medable and Vault Health Partner to Expand Direct-to-Patient Testing and eCare for Decentralized Clinical Trials.

December 8, 2021
·
4 min read
Deals

Reata Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Discuss Bardoxolone for the Treatment of Patients With Chronic Kidney Disease Caused by Alport Syndrome

Reata Pharmaceuticals, Inc announced today that Nasdaq has halted trading of the Company’s common stock.

December 8, 2021
·
3 min read
Genetown

Cytovia Therapeutics’ Scientific Leadership to Present at Upcoming Conferences

Cytovia Therapeutics, Inc. announced today that its scientific leadership will present at the following upcoming conferences: iPSC-Derived Cell Therapies Summit (Virtual Event).

December 8, 2021
·
3 min read
BioMidwest

Stereotaxis Robotic Technology Reduces Incidence of Silent Cerebral Embolism During Atrial Fibrillation Ablation in New Peer-Reviewed Publication

Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a publication in Frontiers in Cardiovascular Medicine titled “Atrial Fibrillation Ablation Using Robotic Magnetic Navigation Reduces the Incidence of Silent Cerebral Embolism.”

December 8, 2021
·
4 min read
Drug Development

Veru Announces Presentation of Preclinical Evidence Supporting the Therapeutic Benefit of Enobosarm Alone or in Synergistic Combination with a CDK4/6 Inhibitor Against Palbociclib Resistant Metastatic Breast Cancer

Veru Inc. today announced that human preclinical data will be presented at the San Antonio Breast Cancer Symposium being held December 07-10, 2021, in San Antonio, TX.

December 8, 2021
·
10 min read
Drug Development

SOTIO Announces Clinical Collaboration with MSD to Evaluate IL-15 Superagonist, SOT101, in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors

SOTIO Biotech,announced today that it has entered into a clinical trial collaboration and supply agreement with MSD, to evaluate the combination of SOT101, SOTIO’s IL-15 superagonist, and MSD’sKEYTRUDA® (pembrolizumab)in patients with selected advanced/refractory solid tumors in the phase 2 AURELIO-04 study.

December 8, 2021
·
3 min read